Stitch Fix Inc vs Tempus AI — how do they compare? Stitch Fix Inc trades at $2.83 (market cap $366.07M), while Tempus AI trades at $71.11 (market cap $12.58B). The key difference: Tempus AI is far larger — about 34.4× Stitch Fix Inc's market cap, and Tempus AI is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Stitch Fix Inc for 31 Days and Tempus AI for 23 Days on average.
| SFIX | TEM | |
|---|---|---|
Market Cap | $366.07M | $12.58B |
Volume | 5,152,008 | 7,444,569 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $5.64 | $99.28 |
52-Week Low | $2.16 | $41.55 |
Typical Hold Time | 31 Days | 23 Days |
Enterprise Value | $261.88M | $13.21B |
Signals from Pluang's Aura AI — not financial advice
Stitch Fix (SFIX) trades at $2.84, up 4.03% today, but remains under pressure with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly earnings beats and narrowing losses, though it still reports negative net income. Revenue has stabilized around $1.3B after previous declines, with management focusing on AI personalization and category expansion to drive growth.
The outlook remains challenging with weak FY2027 guidance overshadowing recent progress. While valuation appears reasonable with P/S of 0.27, negative profitability metrics and multiple fraud investigations create significant headwinds. Analyst consensus leans neutral with $3.40 price target, suggesting limited upside from current levels amid ongoing business transformation.
Tempus AI (TEM) trades at $71.46, up 1.66% with a bullish technical signal despite negative profitability metrics. The stock shows strong analyst support with 9 buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and 13 ESMO Congress presentations highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist at -$254M.
Outlook remains cautiously optimistic given strong institutional backing and AI healthcare growth potential, but profitability challenges and insider selling present near-term risks. The stock's valuation appears stretched with P/S of 8.61 and P/B of 28.27, requiring sustained revenue acceleration to justify current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →